giving birth

The decision by Covis Pharma to withdraw Makena, their injectable progesterone drug intended to prevent preterm birth, marks a critical turning point in maternal healthcare. The Food and Drug Administration (FDA) advisory panel’s conclusion that Makena is ineffective highlights significant flaws in the drug’s approval process. Originally greenlit in 2011 through the FDA’s accelerated drug
0 Comments
Recent studies, including a stark 2023 report by the CDC, reveal a troubling reality: 20% of women report experiences of mistreatment during labor. These reported incidents range from outright negligence to psychological undermining in the form of verbal attacks and emotional dismissiveness. Such experiences highlight a pervasive issue within maternity care that must be addressed
0 Comments